How to make preclinical animal research more effective
Tuesday, July 23, 2013 - 20:30
in Health & Medicine
Only 11% of drugs that enter clinical trials in humans are ultimately found safe and effective enough to receive regulatory approval. One possible reason for this dismal success rate is flawed preclinical animal research. A number of recent initiatives seek to improve the design and execution of such experiments. Now, a new studyidentifies key procedures believed to address threats to the validity of preclinical findings.